Mirae Asset Global ETFs Holdings
CRDF icon

Mirae Asset Global ETFs Holdings’s Cardiff Oncology CRDF Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$47.7K Buy
29,467
+714
+2% +$1.47K ﹤0.01% 2915
2025
Q4 		$80.8K Sell
28,753
-38
-0.1% -$88 ﹤0.01% 2769
2025
Q3 		$59.3K Sell
28,791
-4,887
-15% -$13.5K ﹤0.01% 2903
2025
Q2 		$106K Sell
33,678
-641
-2% -$1.96K ﹤0.01% 2586
2025
Q1 		$108K Buy
34,319
+11,497
+50% +$45.5K ﹤0.01% 2598
2024
Q4 		$99K Buy
22,822
+988
+5% +$3.09K ﹤0.01% 2703
2024
Q3 		$58.3K Buy
+21,834
New +$51.6K ﹤0.01% 2891

Other funds holding CRDF

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
FLPIM
F.L. Putnam Investment Management Lynnfield, Massachusetts $6.71B AUM 23.99% 1-Year Est. Return